XBI Stock Recent News

XBI LATEST HEADLINES

XBI Stock News Image - zacks.com

Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market.

zacks.com 2024 Jun 25
XBI Stock News Image - schaeffersresearch.com

One of our favorite parts of rolling into a new month at Schaeffer's is digging into seasonality and historic trends of stocks, sectors, and exchange traded funds (ETFs).

schaeffersresearch.com 2024 Jun 06
XBI Stock News Image - investorplace.com

Undervalued biotech stocks can offer some of the most explosive opportunities. That is, if you can spot the right one at the right time.

investorplace.com 2024 Jun 04
XBI Stock News Image - etftrends.com

Sometimes it feels like it's Nvidia's world and we all just live in it. Why bother with anything else?

etftrends.com 2024 May 31
XBI Stock News Image - zacks.com

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the SPDR S&P Biotech ETF (XBI), a passively managed exchange traded fund launched on 01/31/2006.

zacks.com 2024 May 30
XBI Stock News Image - Seeking Alpha

The biotech sector has experienced significant volatility but has returned around the same as the risk-free return from the 10-Year Treasury over the past year. There are two key items that will determine the direction of small and midcap biotech stocks in the months and quarters ahead. These are highlighted in the paragraphs below about SPDR® S&P Biotech ETF.

Seeking Alpha 2024 Apr 30
XBI Stock News Image - Zacks Investment Research

Making its debut on 01/31/2006, smart beta exchange traded fund SPDR S&P Biotech ETF (XBI) provides investors broad exposure to the Health Care ETFs category of the market.

Zacks Investment Research 2024 Apr 23
XBI Stock News Image - Seeking Alpha

SPDR S&P Biotech ETF offers a buying opportunity after a recent decline and trades close to the 200-day moving average. XBI has a strong long-term track record, providing generous total returns for shareholders. The biotech sector is seeing increased levels of merger and acquisition deals, indicating potential undervaluation in biotech stocks.

Seeking Alpha 2024 Apr 19
XBI Stock News Image - CNBC Television

Michelle Ross, StemPoint Capital CIO, joins CNBC's Halftime Report' to discuss her latest biotech pick.

CNBC Television 2024 Apr 03
XBI Stock News Image - Zacks Investment Research

After a strong resurgence in the back half of 2023 and continued momentum into the first quarter of 2024, biotech stocks are back in vogue. “Hawkish” Federal Reserve Policy, a brutal bear market in 2022, and investor preference for big tech stocks have meant underperformance for biotech stocks.

Zacks Investment Research 2024 Mar 28
10 of 50